Olema Oncology is a preclinical biotechnology company that focuses on developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. Their main goal is to transform the standard of care for women living with cancer by developing more convenient and effective therapies. They leverage their deep understanding of endocrine-driven cancers, nuclear receptors, an...